✦ LIBER ✦

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer

✍ Scribed by Athanasios Kotsakis; Sophia Agelaki; Nikolaos Vardakis; George Stathopoulos; Lambros Vamvakas; Antonia Kalykaki; Nikolaos Kentepozidis; Emmanouel Kontopodis; Georgia Sfakiotaki; Dimitris Mavroudis; Vassilis Georgoulias

Publisher: Springer
Year: 2010
Tongue: English
Weight: 184 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1508-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment planning for dose escalation i

Treatment planning for dose escalation in non-small cell lung cancer (NSCLC)

✍ Steven E. Schild; Shawn M. Korte; William W. Wong; Sujay A. Vora; James A. Young 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Dose escalation study of irinotecan comb

Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer

✍ Koji Takeda; Shunichi Negoro; Nobuhide Takifuji; Takashi Nitta; Naruo Yoshimura; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB

Phase I trial of dose escalation of cape

Phase I trial of dose escalation of capecitabine combined with fixed docetaxel in previously treated patients with non-small cell lung cancer

✍ Qiang Lin; Yue’e Liu; Chuilin Chang; Na Wang; Jingmei Fu; Xiaocang Ren; Xueji Ch 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 260 KB

Clinical and pharmacokinetic study of do

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients

✍ Nagio Takigawa; Yoshihiko Segawa; Daizo Kishino; Keiichi Fujiwara; Yoshiyuki Tok 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 212 KB

14. The challenge of dose escalation for

14. The challenge of dose escalation for non-small cell lung cancer (NSCLC): a paradoxal issue

✍ P. Van Houtte; M. Roelandts; C. Mahin 📂 Article 📅 2003 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 97 KB

A phase I dose-escalation and pharmacoki

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer

✍ L. Q. M. Chow; N. Blais; D. J. Jonker; S. A. Laurie; S. G. Diab; C. Canil; M. Mc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 312 KB